| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |